|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||
|
|||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s2B7F460C-60AC-11EF-A5B6-B38B85CE164B&I=39IZM&T=&OP=Display&O=html&O1=15930690&O2=954925388218&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DAbstract%25207617%253A%2520Quantitative%2520continuous%2520scoring%2520of%2520PD-L1%2520for%2520superior%2520patient%2520selection%2520for%2520anti-PD-L1%2520treatment%2520of%2520locally%2520advanced%2520or%2520unresectable%2520NSCLC%26rft.au%3DLesniak%252C%2520Jan%2520Martin%26rft.date%3D2024-03-22%26rft.eissn%3D1538-7445%26rft.epage%3D7617%26rft.externalDBID%3Dn%252Fa%26rft.externalDocID%3D10_1158_1538_7445_AM2024_7617%26rft.genre%3Darticle%26rft.issn%3D1538-7445%26rft.issue%3D6_Supplement%26rft.jtitle%3DCancer%2520research%2520%2528Chicago%252C%2520Ill.%2529%26rft.spage%3D7617%26rft.volume%3D84%26rft_id%3Dinfo%253Adoi%252F10.1158%252F1538-7445.AM2024-7617%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-SINGLE_JOURNALS-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-NCBI_PUBMED_FREE-getAbstract-object,6-ISI_WEB_OF_SCIENCE-getAuthor-object,7-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,8-REFWORKS_EXPORT_TOOL-getReference-object,9-SHERPA_RoMEO_LCL-getWebService-object,10-GOOGLE_SCHOLAR_FREE-getWebSearch-object,11-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.998351&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15930690-s2B7F460C-60AC-11EF-A5B6-B38B85CE164B" timestamp="2024-08-22T19:30:06Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925388218</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Abstract 7617: Quantitative continuous scoring of PD-L1 for superior patient selection for anti-PD-L1 treatment of locally advanced or unresectable NSCLC</jnl:atitle>
<jnl:jtitle>Cancer Research</jnl:jtitle>
<jnl:date>2024-03-22</jnl:date>
<jnl:spage>7617</jnl:spage>
<jnl:epage>7617</jnl:epage>
<jnl:coden>CNREA8</jnl:coden>
<jnl:issn>0008-5472</jnl:issn>
<jnl:volume>84</jnl:volume>
<jnl:issue>6_Supplement</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1538-7445</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>CNREA8</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:c493267bdfd6d0bb0da1ee0dd59647e648e9a545</ctx:identifier>
<ctx:identifier>urn:UUID:s2B7F460C-60AC-11EF-A5B6-B38B85CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)